Clinical trial · Interventional
Smart After-Care in Patients With Prostate Cancer
Smart After-Care in Patients With Prostate Cancer: a Randomized Controlled Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to examine whether Smart After-Care service (Internet-and mobile-based lifestyle intervention) has an effect on patients' satisfaction and clinical outcomes in patients with prostate cancer on androgen deprivation therapy. Patients with prostate cancer on androgen deprivation therapy will participate in the study. The study design is a randomized controlled trial. The patients were randomly assigned to intervention or usual care groups. Intervention patients received Smart After-Care service for 3 months. Primary endpoint was an increase in patients' physical function as assessed using 2 minute walking test. Secondary endpoints included improvement in muscle strength, short physical performance battery, body composition, and health-related quality of life.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Smart After-Care (Mobile health) | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention: Case management
- description
- Case management consists confirmation of hospital visit date, checking the efficacy of intervention, adverse effect and treatment compliance
- interventionNames
- Behavioral: Smart After-Care (Mobile health)
- type
- NO_INTERVENTION
- label
- Control: usual care
- description
- Usual care is provided with life style intervention including exercise and nutrition by printed materials.
Primary outcomes (1)
- measure
- Physical function (2 minute walking test)
- timeFrame
- 3 months after randomization
- description
- Cardiorespiratory endurance was examined by 2MWT performed on a 15.2-m hallway out-and-back course. Patients were instructed to walk as fast as they could until asked to stop at 2 min; the distance covered was recorded.
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 40 Years
Show eligibility criteria text
Inclusion Criteria: * Males diagnosed with prostate cancer * Current treatment with ADT (GnRH agonist/antagonist with or without antiandrogen) for a minimum of 6 months after randomization * Having Android smartphone Exclusion Criteria: * Having another (active) malignant disease within 3 month before randomization * Having severe cardiopulmonary disease * Having bone pain due to bone metastasis, (or) pathologic fracture * Receiving total knee replacement arthroplasty, (or) total hip replacement arthroplasty * No permission from treating/study physician to participate in exercise
References
Publications (0)
Data not yet available